GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

The PCR reaction involves repeat cycles through a series of temperature which yields many copies of the target region to be replicated. Global polymerase chain reaction market generated a revenue of $XX billion in 2018 & is projected to reach $13,644 million by 2027, at a CAGR of 6.19% during the forecasting years of 2019-2027. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.

GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

Global Polymerase Chain Reaction Market by Technology (Real-time Pcr, Traditional Pcr, Digital Pcr) by Product (Reagent and Consumables, Instruments, Software, Services) by Application (Clinical, Research, Forensics) by End-user (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic and Research Institutes) by Geography.

Request free sample

Global polymerase chain reaction market refers to the method that produces abundant copies of a target DNA region in vitro. This chain reaction depends on a thermostable DNA polymerase called TAQ polymerase, which is extracted from Thermus aquaticus and as the name suggests, they live in hot springs and hydrothermal vents. The PCR reaction involves repeat cycles through a series of temperature which yields many copies of the target region to be replicated. Global polymerase chain reaction market generated a revenue of $XX billion in 2018 & is projected to reach $13,644 million by 2027, at a CAGR of 6.19% during the forecasting years of 2019-2027. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027. The key factors that are responsible for the market advancement are:

  • Reagents and consumables hold the largest market share
  • Rise in infectious diseases worldwide
  • Increasing demand for digital PCR (d-PCR)

Global polymerase chain reaction market is primarily driven by increasing prevalence of infectious diseases and the growing geriatric population. The increasing investments by the key players coupled with rapid changes in technology are the prime factors which are fueling the growth of the market. The advent of newer PCR techniques will be leading to a shorter throughput time and an increased sensitivity which is fueling the growth of the polymerase chain reaction market in the forecast period 2019-2027.

In 2018, the academic and research institutes in polymerase chain reaction market accounted for the largest share of 46.91% in the end-user segment. The segment for academic and research institutes is primarily driven by the increasing initiatives of research activities coupled with the revolution of products is driving the growth of this segment in the forecast period. Growth in the strategic initiatives by the company coupled with demand for personalized medicine has further boosted the growth of the company.

In total, increasing inclination for personalized medicine is also spreading the growth projections for this segment coupled with increasing investments in genomics and drug discovery is boosting the growth of the polymerase chain reaction market in the forecast period 2019-2027.

With the growing acceptance of polymerase chain reaction techniques, the global market is also facing some challenges. The inability of the conventional PCR technique to target complex endpoint sequences is limiting the growth of the PCR in the forecast period. The availability of alternative technologies for DNA sequencing is also probing as a challenge to the market in the coming years.

Moreover, the high cost of instruments and the high cost of labor is further obstructing the growth of the global market.

Report scope of global polymerase chain reaction market covers segmentation by technology, product, end-user, application and region.

Market by Technology:

  • Real-Time PCR
  • Traditional PCR
  • Digital PCR

Market by Product:

  • Reagents and Consumables
  • Instruments
  • Software
  • Services

Market by Application:

  • Clinical
  • Research
  • Forensics

Market by End-User:

  • Diagnostic Centers & Hospitals
  • Biotech & Pharma Companies
  • Academic & Research Institutions

Geographically, the global polymerase chain reaction market has been segmented on the basis of four major regions, which are:

North America is the dominant region for polymerase chain reaction market with around 41% market share in 2018 in terms of revenue. The dominance of North America is attributed to the fact of the presence of the majority of the key players that are offering the services in the region. The key players are Hoffman La Roche Ltd. (U.S.), Agilent Technologies Inc. (U.S), and many others.

Further, the North America polymerase chain reaction market is rising rapidly owing to the infectious and chronic diseases such as HIV/AIDS, hepatitis, and cancer in concurrence with an increasing number of R&D activities by biotechnological & pharmaceutical companies in the region. According to the Centers for Disease Control and Prevention (CDC), $xx million people in the U.S. are affected by HIV. Moreover, the increasing rate of laboratory usage for PCR in proteomics and genomics is boosting the growth of PCRs in the region coupled with new product developments in the region is boosting the growth of the North America polymerase chain reaction market.

The Asia Pacific is the fastest growing regional market during the forecast period. The fastest growth rate of Asia Pacific is attributed to many factors such as the rising prevalence of infectious diseases increase in R&D investments and stiff competition by the market players which is boosting the growth emerging economies of India, China, Japan, and Thailand.

Bio Rad Laboratories Inc. has launched first of its kind RT-PCR Systems, which features facial verification, voice instructions, radio-frequency identification (RFID)-plate scanning, and access to service and support. This will further boost the polymerase chain reaction market. Also, the increasing collaborations and mergers between key players for launching innovative products with more efficient polymerase chain reaction techniques will further fuel the market growth in the future.

Global polymerase chain reaction market has been segmented by technology, product, end-user, and application. The end-user industry segment is further sub-segmented into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Product type comprises of reagents & consumables, instruments, software and services. The application segment comprises of clinical, research and forensics.

The market has a number of players, and some of the key players involved in the global polymerase chain reaction market are:

  • Agilent Technologies Inc.
  • Qiagen N.V.
  • F. Hoffman La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Others

The company profiles of prominent market players are discussed in detail. Most of the companies are looking for strategies such as merger & acquisition, partnership, contracts, agreements & new product launch, to gain a competitive edge over other companies. For instance, in April 2019, Agilent launched a system which brands quality control in next-generation sequencing easier, faster and economical. This development will reduce the time taken to carry out a sequencing generation faster.

Key findings of the global polymerase chain reaction market:

  • North America leads the global polymerase chain reaction market by capturing the largest market share of around 41% in 2018.
  • The focus of market players is to pace up the R&D capabilities coupled with the innovation of new products.
  • Asia Pacific global polymerase chain reaction market is anticipated to grow at the highest CAGR of XX% during the forecast period of 2019-2027.
  • Growth in the trend of the increasing prevalence of infectious diseases worldwide.
  • The demand for digital PCR systems is boosting the growth of the market in the forecast period 2019-2027.
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
      • RISE IN INFECTIOUS DISEASES WORLDWIDE
      • INCREASING DEMAND FOR DIGITAL PCR
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • RISING INCIDENCES OF INFECTIONS AND DISEASES
      • DEVELOPMENT IN PHARMACOGENOMICS
      • EMERGENCE OF DIGITAL PCR
      • INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
    • MARKET RESTRAINTS
      • NON-VALIDATED HOME BREW TESTS
      • HIGH DEVICE COSTS ASSOCIATED WITH PCR
      • NECESSITY OF TRAINING AND UPDATION OF LABORATORIES WORKERS
    • MARKET OPPORTUNITIES
      • RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
      • EXPANDING HEALTHCARE MARKET IN APAC
    • MARKET CHALLENGES
      • INACCURACY CAUSED BY THE PCR TECHNIQUES
      • INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END-USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES INC.
      • BIORAD TECHNOLOGIES INC.
      • QIAGEN N.V.
      • HOFFMAN LA ROCHE LTD.
      • THERMOFISHER SCIENTIFIC INC.
      • ABBOTT LABORATORIES
      • BECTON DICKINSON BIOSCIENCES SYSTEMS AND   REAGENTS INC.
      • SIEMENS HEALTHINEERS
      • BIOMERIEUX SA
      • DANAHER CORPORATION
      • MDXHEALTH CORPORATION
      • NANO BIOSYS INC.
      • TAHARA BIO INC.
      • FLUIDIGM CORPORATION
      • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

 

LIST OF TABLES

TABLE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)

TABLE 3. GLOBAL PCR MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)

TABLE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)

TABLE 5. GLOBAL REAGENT AND CONSUMABLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 6. GLOBAL INSTRUMENTS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 7. GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 8. GLOBAL SERVICES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY APPLICATION, 2019-2027, (IN $ MILLION)

TABLE 10. GLOBAL CLINICAL MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 11. GLOBAL RESEARCH MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 12. GLOBAL FORENSICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY END USER 2019-2027, (IN $ MILLION)

TABLE 14. GLOBAL DIAGNOSTIC CENTERS & HOSPITALS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 15. GLOBAL BIOTECH AND PHARMA COMPANIES  MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 17. OPPORTUNITY MATRIX

TABLE 18. VENDOR LANDSCAPE

TABLE 19. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)

TABLE 20. NORTH AMERICA POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 21. EUROPE POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 22. ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 23. REST OF WORLD POLYMERASE CHAIN (PCR) MARKET, BY REGION, 2019-2027 (IN $ MILLION)

 

LIST OF FIGURES

FIGURE 1. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TYPE, 2018 & 2027 (IN %)

FIGURE 2. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)

FIGURE 3. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)

FIGURE 4. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)

FIGURE 5. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 6. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)

FIGURE 7. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)

FIGURE 8. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)

FIGURE 9. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)

FIGURE 10. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)

FIGURE 11. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)

FIGURE 12. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)

FIGURE 13. GLOBAL POLYMERASE CHAIN (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)

FIGURE 14. PORTER’S FIVE FORCE ANALYSIS

FIGURE 15. GLOBAL POLYMERASE CHAIN (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 16. UNITED STATES POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 17. CANADA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 18. UNITED KINGDOM POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19. GERMANY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20. FRANCE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21. SPAIN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22. ITALY POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 23. REST OF EUROPE POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 24. CHINA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 25. JAPAN POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 26. INDIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 27. SOUTH KOREA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 28. AUSTRALIA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 29. REST OF ASIA PACIFIC POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 30. LATIN AMERICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 31. MIDDLE EAST & AFRICA POLYMERASE CHAIN (PCR) MARKET, 2019-2027 (IN $ MILLION)

  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END-USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now